The caspase-3 inhibitor z-DEVD was used to determine whether caspase-3-dependent apoptosis contributed to the hemorrhage pathogenesis induced in vivo by the rEIII and autoantibody challenges, in line with our previously established mouse model [25]. The gene discussed is CASP3; the disease is hemorrhage.